News

Back to News

Global Trials Focus

[vc_row][vc_column][vc_column_text]Every month the ISN-ACT Team lists interesting new randomized controlled trials (RCTs) from around the world.

Highlight:

  • SGLT-2 inhibition strikes again
    Dapagliflozin in Patients with Chronic Kidney Disease

See the latest trials here.

A summary of the highlighted trial is now available in French, Mandarin, and Spanish.

Support equal access to nephrology research: Become an ISN Member![/vc_column_text][/vc_column][/vc_row]

Help us advance kidney health worldwide
Join the ISN
Back to News